Impaired granulocytic function in patients with acute leukaemia: Only partial normalisation after successful remission-inducing treatment

Journal of Cancer Research and Clinical Oncology

Volumn 124, Issue 2, 1998, Pages 113-116

  Hofmann, Wolf Karsten ^a,b   Stauch, Martina ^a   Höffken, Klaus ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Acute lymphoblastic leukaemia; Acute myeloid leukemia; Granulocytic function

Indexed keywords

ACUTE LEUKEMIA; ARTICLE; CELL FUNCTION; CELL MOTILITY; CLINICAL ARTICLE; GRANULOCYTE; HUMAN; HUMAN CELL; HUMAN TISSUE; MYELOID LEUKEMIA; PHAGOCYTOSIS; PREDICTION; PRIORITY JOURNAL; REMISSION;

ADOLESCENT; ADULT; AGED; CHEMOTAXIS; FEMALE; GRANULOCYTES; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; MIDDLE AGED; PHAGOCYTOSIS; REMISSION INDUCTION;

EID: 0031924409     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004320050142     Document Type: Article

References (24)

1. Amar M, Amit N, Scoazec JY, Pasquier C, Babin-Chevaye C, Huu TP, Makim J (1992) K562 cells produce an anti-inflammatory factor that inhibits neutrophil functions in vivo. Blood 80:1546-1552
2. Bendix-Hansen K (1986) Myeloperoxidase-deficient polymorphonuclear leukocytes. Longitudinal study during the preremission and the remission phase in acute myeloid leukaemia. Comparison to neutrophil alkaline phosphatase activity. Blut 52:237-242
3. Bendix-Hansen K, Helleberg-Rasmussen I (1985) Evaluation of neutrophil alkaline phosphatase activity: untreated myeloid leukaemia, lymphoid leukaemia and normal humans. Scand J Haematol 34:264-269
4. Bendix-Hansen K, Kaspersen-Nielsen H (1983) Myeloperoxidase-deficient polymorphonuclear leukocytes. I. Incidence in untreated myeloid leukaemia, lymphoid leukaemia and normal humans. Scand J Haematol 30:415-419
5. Bendix-Hansen K, Nielsen HK (1983) Myeloperoxidase-deficient polymorphonuclear leukocytes. II. Longitudinal study in acute myeloid leukaemia, untreated, in remission and in relaps. Scand J Haematol 31:5-8
6. Bendix-Hansen K, Nielsen HK (1985) Myeloperoxidase-deficient polymorphonuclear leukocytes. IV. Relation to FAB-classification in acute myeloid leukaemia. Scand J Haematol 35:174-177
7. Birgens HS, Karle H, Hansen NE, Ostergaard-Kristensen L (1984) Lactoferrin receptors in normal and leukaemic human blood cells. Scand J Haematol 33:275-280
8. Bottari V, Fattorossi A, Nisini R, Petti MC, Fenu S, Fontana L (1987) Motility and oxidative metabolism of normal polymorphonuclear leukocytes in acute non-lymphoid leukemia in complete remission. Clin Lab 17:41-46
9. Davey FR, Erber WN, Gatter KC, Mason DY (1988) Abnormal neutrophils in acute myeloid leukemia and myelodysplastic syndrome. Hum Pathol 19:454-459
10. Guseva SA (1985) Antibody-dependent cell-mediated cytotoxicity of peripheral blood neutrophils in vitro in acute leukaemia. Cytologia 27:1067-1070
11. Guseva SA (1990) The characteristics of the oxidative metabolism of the blood neutrophils in patients with acute mycloblastic leukemia. Arch Pathol 52:12-15
12. Huebner K, Isobe M, Croce CM, Golde DW, Kaufman SE, Gasson JC (1985) The human gene encoding GM-CSF is at 5q21 q32, the chromosome region deleted in the 5q-anomaly. Science 230:1282-1285
13. Lafrudo LJ, Olsen RG (1986) Demonstration of depressed polymorphonuclear leukocyte function in nonviremie FeLV-infected cats. Cancer Invest 4:297-300
14. Martin E, Bhakdi S (1991) Quantitative analysis of opsonophagocytosis and of killing of Candida albicans by human peripheral blood leukocytes by using flow cytometry. J Clin Microbiol 29:2013-2023
15. Miller ME (1975) Pathology of chemotaxis and random mobility. Semin Hematol 12:59-82
16. Nielsen HK, Bendix-Hansen K (1984) Myeloperoxidase-deficient polymorphonuclear leukocytes. III. Relation to incidence of infection in acute myeloid leukaemia. Scand J Haematol 33:75-79
17. Ruffert K, Jorke D, Krombholz B, Otto K (1979) Stimulierte Granulozytenmobilisation bei Normalpersonen und bei Patienten mit Granulozytopenie. Fol Haematol (Leipz) 106:558-576
18. Schofield KP, Stone PC, Stuart J (1983) Quantitative cytochemistry of blood neutrophils in acute myeloid leukaemia. Br J Haematol 54:261-268
19. Senn HJ (1978) Störungen der Leukozytenfunktion. Methodik der Untersuchung und klinische Aspekte. In: Löhr G, Arnold H, Engelhardt R, Möbius W (eds) Probleme der Erythropoese, Granulopoese und des malignen Melanoms. Springer, Heidelberg Berlin New York, pp 341-353
20. Suda T, Onai T, Maekawa T (1983) Studies on abnormal polymorphonuclear neutrophils in acute myelogenous leukemia: clinical significance and changes after chemotherapy. Am J Hematol 15:45-56
21. Suss J, Bakacs T, Balazs C (1982) The phagocytosis assay: a new radiometric phagozytosis test for clinical use. J Immunol Methods 53:69-75
22. Tobler A, Selsted ME, Miller CW, Johnson KR, Novotny MJ, Rovera G, Koeffler HP (1989) Evidence for a pretranslational defect in hereditary and acquired myeloperoxidase deficiency. Blood 73:1980-1986
23. Truong MJ, Gruart V, Kusnierz, JP, Papin JP, Loiseau S, Capron A, Capron M (1993) Human neutrophils express immunoglobulin E binding proteins (Mac-2/epsilon BP) of the S-type lectin family: role in IgE-dependent activation. J Exp Med 177:243-348
24. Wiernik PH, Banks PLC, Case DC Jr, Arlin ZA, Penman PO, Todd MB, Ritch PS, Enck RE, Weitberg AB (1992) Cytarabine plus idarubicin or daunorubicin as induction and consolidation therapy for previously untreated adult patients with acute myeloid leukemia. Blood 79:313-319